Industry Focus
Healthcare: How Amgen Could Side-Step The Sting of Patent Expiration
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:14:29
- Mas informaciones
Informações:
Sinopsis
Expiring patents threaten billions of dollars in sales at Amgen. Here's what the company is doing to offset the threat to some of its best selling drugs.
